Clinical Trial: The PRO-SOma COla (PROSOCO) Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: Evaluating the Release of the Entero-pancreatic Hormone Somatostatin by Measuring Stable Co-secreted Prosomatostatin Moieties in the Plasma of Healthy Individuals - the PRO-SOma COla (PROSOCO) Study
Brief Summary:
The goal of this randomized, double-blind, placebo-controlled, crossover study is to determine whether it is possible to gauge the pattern of somatostatin secretion by measuring plasma concentrations of pro-somatostatin 1-64 (a stable peptide that is released in equimolar amounts alongside somatostatin) as a surrogate marker.During the study the release of somatostatin will be manipulated by changing the luminal pH of the stomach.Healthy participants will be studied in a randomized on two occasions.The day before…
Read more